Earlier this year, the Chancery Court held that a standard contractual integration clause was insufficient to bar claims premised on a buyer’s alleged assurances to assist in growing the target’s business post-closing. Last week, in Cytotheryx, Inc. v. Castle Creek Biosciences, (Del. Ch.; 10/24), the Chancery Court reached the same conclusion in the context of a buyer CEO’s […]